Results 201 to 210 of about 94,031 (266)

Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition. [PDF]

Biomolecules
Fujimura T, Muto Y, Asano Y.
europepmc   +1 more source

Effectiveness of intravenous recombinant plasminogen activator treatment in Chinese patients with acute ischaemic stroke aged over 80 years: a retrospective cohort study. [PDF]

Stroke Vasc Neurol
Yang J, Huang YH, Zhong W, Gong X, Chen Y, Chen Z, Jin H, Yan S, Huang L, Yuan CZ, Lou M.   +10 more
europepmc   +1 more source

Plasminogen activator Inhibitor-1 in systemic sclerosis: A nexus of fibrosis, vasculopathy, and senescence. [PDF]

Biomed J
Takahashi T, Takahashi T, Asano Y.
europepmc   +1 more source

Tissue Plasminogen Activator as an Approved Strategy for Ischemic Stroke: A Review of tPA's Structure, Mechanism of Action and the Novel Targeting Methods. [PDF]

J Mol Neurosci
Didehvar K, Haghshenas M, Yarmohammadi R, Hajikarimloo B, Ghafoury R.   +4 more
europepmc   +1 more source

Thrombolytic therapy efficacy in cardiopulmonary resuscitation: Investigating the effect of recombinant tissue plasminogen activator (Review). [PDF]

Mol Med Rep
Zhang W, Pan Y, Ding J, Xu D, Wang W.
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Studies on the kinetics of plasminogen activation by tissue plasminogen activator

BBA - Proteins and Proteomics, 1982
The steady-state rate of plasminogen activation by tissue plasminogen activator has been determined at various plasminogen concentrations. A plasmin substrate method similar to that presented by Christensen and Müllertz (Biochim. Biophys. Acta 480 (1977) 257-281) was used.
Mats Rånby
exaly   +3 more sources